Communication

DGAP-News: ecotel communication ag: ecotel presents half-year figures: continued significant improvement in revenue

星期四, 八月 5, 2021 - 8:01am

Net financial assets increased to 5.2 million (12/31/2020: 2.3 million)

Key Points: 
  • Net financial assets increased to 5.2 million (12/31/2020: 2.3 million)
    The first half-year 2021 has been very successful for the ecotel Group.
  • This means that ecotel has been able to achieve substantial increases in consolidated profit and also earnings per share.
  • The easybell segment continued to grow undiminished, in revenue by 19 % to 12.3 million and by 39% in gross profit to 6.9 million.
  • The ecotel Group (hereinafter ecotel), operating throughout Germany since 1998, specializes in the marketing of IT and telecommunications solutions in various segments.

WMG Acquisition Corp. Announces Launch of Senior Secured Notes Offering

星期四, 八月 5, 2021 - 7:45am

NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Warner Music Group Corp. (Warner Music Group or WMG) announced today that through its wholly owned subsidiary WMG Acquisition Corp. (the Company) it has commenced a private offering (the Notes Offering) of euro-denominated senior secured notes (the Notes).

Key Points: 
  • NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Warner Music Group Corp. (Warner Music Group or WMG) announced today that through its wholly owned subsidiary WMG Acquisition Corp. (the Company) it has commenced a private offering (the Notes Offering) of euro-denominated senior secured notes (the Notes).
  • The Notes will be offered in a private offering exempt from the registration requirements of the United States Securities Act of 1933, as amended (the Securities Act).
  • The Notes Offering is being made only by the Offering Circular being sent to prospective investors.
  • These forward-looking statements include statements regarding expectations as to the completion of the Offering and the redemption of the 3.625% senior secured notes due 2026.

Caverion Corporation's Half-year Financial Report for 1 January - 30 June 2021

星期四, 八月 5, 2021 - 7:17am

Our operating cash flow before financial and tax items was EUR 37.2 (104.3) million in January-June 2021 and the cash conversion (LTM) was 80.3 (160.7) percent.

Key Points: 
  • Our operating cash flow before financial and tax items was EUR 37.2 (104.3) million in January-June 2021 and the cash conversion (LTM) was 80.3 (160.7) percent.
  • Caverion expects market demand to be overall positive in Services and to gradually improve also in Projects in the second half of 2021.
  • Caverion will hold an online news conference on its Half-year Financial Report on Thursday, 5 August 2021, at 10.00 a.m. Finnish time (EEST).
  • Q3 Interim Report will be published on 4 November 2021 and Financial Statement Release for 2021 on 10 February 2022 at 8:00 a.m. (EET).

Wallbox Closes First Half 2021 With Over 300% YOY Revenue Growth, Propelled By Global Expansion, Strategic Alliances And Growing Tailwinds

星期四, 八月 5, 2021 - 6:03am

First half 2021 revenues increased more than 300% versus first half 2020 and were 15% ahead of budgeted expectations.

Key Points: 
  • First half 2021 revenues increased more than 300% versus first half 2020 and were 15% ahead of budgeted expectations.
  • In the period ended June 30, 2021, we achieved $32 million in revenues, which exceeded our budgeted projections by approximately 15% and was 30% greater than full-year 2020 revenue.
  • Over performing our budget in the first half of the year, along with several recently announced and ongoing initiatives, position us well to deliver on our previously disclosed full-year 2021 revenue target.
  • Wallbox is a global company, dedicated to changing the way the world uses energy in the electric vehicle industry.

Imugene and Celularity Announce an Exclusive Strategic Partnership to Develop a Novel Oncolytic Virus - Allogeneic CAR T-Cell Immunotherapy Combination for the Treatment of Solid Tumors

星期四, 八月 5, 2021 - 12:00am

They did this successfully in triple-negative breast, pancreatic, prostate, ovarian, head and neck, and brain cancer cell lines.

Key Points: 
  • They did this successfully in triple-negative breast, pancreatic, prostate, ovarian, head and neck, and brain cancer cell lines.
  • CF33-CD19 oncolytic virus was then combined with CD19 CAR T cells in vitro and in vivo mice studies.
  • Researchers showed significant activity with mice being cured of their cancer with the CF33-CD19 and CAR T-cell combination, as well as prolonged protective anti-tumor immunity.
  • The first clinical trial is anticipated to start in 2022 and will evaluate the safety and efficacy of CF33-CD19 in combination with CAR T therapy in patients with solid tumors.

First Bank and OceanFirst Bank Announce Definitive Agreement for First Bank to Acquire Two Branch Locations in Central New Jersey Region

星期三, 八月 4, 2021 - 9:45pm

HAMILTON, N.J. and RED BANK, N.J., Aug. 04, 2021 (GLOBE NEWSWIRE) -- First Bank (NASDAQ: FRBA) and OceanFirst Bank, N.A.

Key Points: 
  • HAMILTON, N.J. and RED BANK, N.J., Aug. 04, 2021 (GLOBE NEWSWIRE) -- First Bank (NASDAQ: FRBA) and OceanFirst Bank, N.A.
  • (OceanFirst Bank), the banking subsidiary of OceanFirst Financial Corp. (OceanFirst) (NASDAQ: OCFC), today announced the execution of a definitive agreement whereby First Bank will acquire two New Jersey branch locations from OceanFirst Bank.
  • The two branches will continue operating as OceanFirst Bank branches until the transaction is approved and completed.
  • Troutman Pepper provided legal counsel to First Bank and Luse Gorman, PC provided legal counsel to OceanFirst Bank.

First Bank and OceanFirst Bank Announce Definitive Agreement for First Bank to Acquire Two Branch Locations in Central New Jersey Region

星期三, 八月 4, 2021 - 9:30pm

HAMILTON, N.J. and RED BANK, N.J., Aug. 04, 2021 (GLOBE NEWSWIRE) -- First Bank (NASDAQ: FRBA) and OceanFirst Bank, N.A.

Key Points: 
  • HAMILTON, N.J. and RED BANK, N.J., Aug. 04, 2021 (GLOBE NEWSWIRE) -- First Bank (NASDAQ: FRBA) and OceanFirst Bank, N.A.
  • (OceanFirst Bank), the banking subsidiary of OceanFirst Financial Corp. (OceanFirst) (NASDAQ: OCFC), today announced the execution of a definitive agreement whereby First Bank will acquire two New Jersey branch locations from OceanFirst Bank.
  • The two branches will continue operating as OceanFirst Bank branches until the transaction is approved and completed.
  • Troutman Pepper provided legal counsel to First Bank and Luse Gorman, PC provided legal counsel to OceanFirst Bank.

CSPi to Announce Fiscal Third Quarter Financial Results on Wednesday August 11th

星期三, 八月 4, 2021 - 9:30pm

CSPi President and Chief Executive Officer Victor Dellovo and Chief Financial Officer Gary W. Levine will host a conference call at 10:00 a.m.

Key Points: 
  • CSPi President and Chief Executive Officer Victor Dellovo and Chief Financial Officer Gary W. Levine will host a conference call at 10:00 a.m.
  • ET that day to review the financial results and provide a business update.
  • To listen to a live webcast of the call, please visit the Investor Relations section of the Companys website at http://www.cspi.com /.
  • CSPi (NASDAQ: CSPI) operates two divisions, each with unique expertise in designing and implementing technology solutions to help their customers use technology as a means to success.

OneMain Holdings, Inc. Announces Pricing of Upsized $600 Million Aggregate Principal Amount of Senior Notes due 2028

星期三, 八月 4, 2021 - 9:47pm

OneMain Holdings, Inc. (NYSE: OMF) (OMH) announced today that its direct, wholly-owned subsidiary OneMain Finance Corporation (OMFC) priced $600 million aggregate principal amount of its 3.875% senior notes due 2028 (the 2028 notes) in connection with its previously announced registered 2028 notes offering.

Key Points: 
  • OneMain Holdings, Inc. (NYSE: OMF) (OMH) announced today that its direct, wholly-owned subsidiary OneMain Finance Corporation (OMFC) priced $600 million aggregate principal amount of its 3.875% senior notes due 2028 (the 2028 notes) in connection with its previously announced registered 2028 notes offering.
  • The size of the 2028 notes offering has been upsized from $500 million to $600 million.
  • The closing of the offering is expected to occur on August 11, 2021, subject to satisfaction of customary closing conditions.
  • The 2028 notes offering is being made only by means of a prospectus supplement and accompanying base prospectus.

MAIA Biotechnology, Inc. Announces Additions to Executive Team and Board of Directors

星期三, 八月 4, 2021 - 9:12pm

Mihail is a distinguished physician scientist and accomplished drug developer who has brought numerous oncology drugs to patients in need.

Key Points: 
  • Mihail is a distinguished physician scientist and accomplished drug developer who has brought numerous oncology drugs to patients in need.
  • Dr. Obrocea has played an instrumental role in the development and commercialization of numerous drugs, including IMBRUVICA, BESPONSA, and BREYANZI.
  • MAIA cautions that all statements, other than statements of historical facts, contained in this press release, are forward-looking statements.
  • In this release, unless the context requires otherwise, MAIA, Company, we, our, and us refers to MAIA Biotechnology, Inc. and its subsidiaries.